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In Brief
Invariant natural killer T (iNKT) cells help B
cell antibody production, but how B cells
reciprocally modulate iNKT cell re-
sponses is less clear. Tan et al. now iden-
tify inappropriate presentation of CD1d-
restricted self-lipids by autoimmune B
cells as a primary mechanism leading to
iNKT cell hyperactivation, proliferation,
and apoptosis in autoimmunemice. Auto-
immune B cells are shown to have an
altered lipidome, suggesting that this is
linked to iNKT homeostasis.
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Invariant natural killer T (iNKT) cells provide cognate
help via CD1d to lipid antigen-presenting B cells for
antibody production, but whether B cells reciprocally
regulate iNKT cells remains largely unexplored. Here,
we found peripheral, but not thymic, iNKT cells to be
numerically reduced in autoimmune mice lacking Fas
specifically in B cells. The residual iNKT cells were
antigenically overstimulated, had altered cytokine
production, and manifested enhanced proliferation
and apoptosis. B cell-specific ablation of CD1d
ameliorated these iNKTdefects, suggesting that inap-
propriate presentation of CD1d-restricted self-lipids
by autoimmune B cell-depleted peripheral iNKT cells.
CD1d+ autoimmuneBcells have reduceda-galactosi-
dase A expression and, as revealed by lipidomic
profiling, altered lipidomewith aberrant accumulation
of certain self-lipids and reduction of others. These
findings unveil a critical link between autoimmunity,
B cell lipidome, and the maintenance of peripheral
iNKT cells and highlight an essential homeostatic
function of B cells beyond antibody production.
INTRODUCTION
Invariant natural killer T (iNKT) cells are specialized T cells
bearing NK lineage receptors and T cell receptors (TCRs)
comprising an invariant Va-Ja chain preferentially associated
with a limited set of Vb chains that recognize glycolipid antigens
presented by CD1d (Bendelac et al., 2007). These antigens
include glycosphingolipids such as a-galactosylceramide
(a-GalCer) (Kawano et al., 1997) and isoglobotrihexosylceramide
(Zhou et al., 2004) and glycolipids from Gram-negative (Kinjo
et al., 2005; Mattner et al., 2005) and Gram-positive (Kinjo24 Cell Reports 9, 24–31, October 9, 2014 ª2014 The Authorset al., 2011) bacteria. Recognition of foreign and self-lipids is
critical to the immunomodulatory functions of iNKT cells
(Godfrey and Kronenberg, 2004; Taniguchi et al., 2003), which
include the promotion of B cell antibody production, plasma
cell generation, and memory B cell recall responses (Barral
et al., 2008; Galli et al., 2007; Leadbetter et al., 2008; Tonti
et al., 2009).
How B cells in turn modulate iNKT cell responses is far less
known. Human B cells capture exogenous lipid antigens using
apolipoprotein E and low-density lipoprotein receptor, leading
to enhanced lipid presentation via CD1d to iNKT cells (Allan
et al., 2009). Splenic marginal zone (MZ) B cells also trigger
iNKT cells to proliferate and produce interleukin-4 (IL-4) and
IL-13 (Zietara et al., 2011) and preferentially provide cytokine
signals to dendritic cells for optimal iNKT activation (Bialecki
et al., 2009). Recently, B cells from systemic lupus erythemato-
sus (SLE) patients were shown to activate iNKT cells poorly
compared with those from healthy donors and resulted in
reduced iNKT cell frequencies in their peripheral blood (Bosma
et al., 2012). A similar decrease in iNKT cells was observed in pa-
tients with type 1 diabetes (Kukreja et al., 2002) and inflammatory
arthritis (Tudhope et al., 2010). However, it was not clear if iNKT
reduction resulted from genetic mutations affecting iNKT cells
intrinsically or extrinsically via antigen-presenting cells or both.
Moreover, studies with human blood leukocytesmight not reflect
how B and iNKT cells interact in peripheral organs.
Here, we found peripheral iNKT cells to be hyperactivated but
numerically reduced inmice with FAS (CD95, Apo-1) ablated in B
cells (Hao et al., 2008). Further analysis revealed autoimmune B
cells have altered lipidome and disrupted iNKT cell homeostasis
in a CD1d-dependent manner.
RESULTS AND DISCUSSION
iNKT cells were reported to be numerically reduced in germline
MRL-lpr (Fas mutant) mice and autoimmune patients (Bosma
et al., 2012; Yang et al., 2003), although it was not clear why
Figure 1. Reduced Peripheral iNKT Frequencies and Numbers in Autoimmune Fasf/fCd19Cre/+ Mice
(A and B) Frequencies (A) and numbers (B) of iNKT cells in spleens, livers, bone marrows and thymi of 20-week-old Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ mice as
enumerated by flow cytometry.
(C) Rearranged Va14-Ja18 transcript levels in Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ splenocytes as assessed by quantitative real-time PCR.
Data in (A) are representative of more than four mice. Each symbol in (B) represents an individual mouse and small horizontal bars indicate the mean. Data in (C)
are mean ± SEM of measurements obtained with four mice of each genotype. *p < 0.01; **p < 0.001; ns, not significant. See also Figure S1.they declined in these subjects. Here, we studied autoimmune
Fasf/fCd19Cre/+ mice lacking FAS in B cells and also found
iNKT frequencies and numbers to be substantially reduced in
spleens, liver and bone marrows of 20-week-old mutants
compared with age-matched Fas+/+Cd19Cre/+ controls (Figures
1A and 1B). This defect was also apparent in young 8-week-
old Fasf/fCd19Cre/+ mice (Figure S1). To exclude the possibility
that the observed reduction in iNKT frequencies was due to cells
internalizing their invariant TCRs, we assessed the levels of
rearranged splenic Va14-Ja18 transcripts (normalized to Ca)
by quantitative real-time PCR. We found them to be lower in
Fasf/fCd19Cre/+ compared with Fas+/+Cd19Cre/+ splenocytes
(Figure 1C), confirming that mutant mice indeed had feweriNKT cells. In contrast, iNKT cell frequencies and numbers in
the thymi of Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+mice were com-
parable. Thus, our data indicate that peripheral, but not thymic,
iNKT cells are perturbed in autoimmune Fasf/fCd19Cre/+ mice.
To understand the cause of iNKT cell diminution in Fasf/f
Cd19Cre/+ mice, we examined their expression of costimulatory
molecules and found higher expression of FAS, PD-1, ICOS,
OX-40, FASL, CD40L, PD-L1, and PD-L2 but normal CD25 and
CD28, suggesting that Fasf/fCd19Cre/+ iNKT cells were hyperacti-
vated comparedwith Fas+/+Cd19Cre/+ counterparts (Figure 2A). In
addition, they have altered cytokine production as a greater frac-
tion (39.5%) of iNKT cells from Fasf/fCd19Cre/+ mice expressed
interferon-g (IFN-g) while a correspondingly lower fractionCell Reports 9, 24–31, October 9, 2014 ª2014 The Authors 25
Figure 2. iNKT Cells in Fasf/fCd19Cre/+ Mice Exhibit Hyperactivation and Altered Cytokine Expression but Respond Normally to External
Stimuli In Vitro and In Vivo
(A–C) Expression of cell-surface molecules on (A) and cytokine production by (B and C) splenic iNKT cells in age-matched Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+
mice.
(D–G) Frequencies of Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ iNKT cells that incorporated BrdU 24 hr after intraperitoneal (i.p.) injection (D and F) or stained positive
for Ki67 ex vivo (E and G).
(H and I) Frequencies of caspase-3-expressing iNKT cells in Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ mice.
(J) Proliferation of CFSE-labeled Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ iNKT cells stimulated with a-GalCer or anti-CD3 and anti-CD28 for 3 days.
(K) Splenic iNKT cell frequencies in Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ mice 3 days after i.p. injection with a-GalCer.
(L) Fold increase in frequency of splenic iNKT cells from Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ mice injected with a-GalCer with respect to mice of same genotype
injected with vehicle alone.
Data in (A)–(E), (H), (J), and (K) are representative of more than threemice of each genotype. Data in (F), (G), (I), and (L) are mean ±SEM of measurements obtained
with four mice. *p < 0.01; ***p < 0.0001; ns, not significant.(6.08%) expressed IL-4 after ex vivo stimulation with phorbol-
12-myristate-13-acetate (PMA) and ionomycin. In contrast,
Fas+/+Cd19Cre/+ iNKT cells predominantly produced IL-4
(34.2%) and less IFN-g (10.4%; Figure 2B). However, the propor-
tion of Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ iNKT cells producing
tumor necrosis factor a (TNF-a) were similar (32.6% versus
31.9%; Figure 2C). Since iNKT cells in Fasf/fCd19Cre/+ mice ap-
peared overactivated, we asked if they exhibited increased prolif-
eration. We found iNKT cells in Fasf/fCd19Cre/+ mice to undergo
more cell divisions as evident from the increased percentage of
cells that incorporated bromodeoxyuridine (BrdU) (12.0%)
compared with Fas+/+Cd19Cre/+ iNKT cells (1.56%; Figures 2D
and 2F). This was corroborated by the elevated frequency of
iNKT cells in Fasf/fCd19Cre/+ mice staining positive for Ki67
(16.8% versus 8.0%; Figures 2E and 2G). Moreover, we found26 Cell Reports 9, 24–31, October 9, 2014 ª2014 The Authorsthe proportion of iNKT cells that expressed activated caspase-3
to be 2-fold higher (22.3%) in Fasf/fCd19Cre/+ compared with
Fas+/+Cd19Cre/+ mice (11.4%; Figures 2H and 2I), suggesting
that these cells had a greater propensity to apoptose. Collectively,
the data suggest thatmost iNKT cells in Fasf/fCd19Cre/+micewere
antigenically overactivated, had altered cytokine profile, and
manifested enhanced cell division and turnover.
Given the hyperactivated phenotype of iNKT cells in Fasf/f
Cd19Cre/+ mice under steady-state conditions in vivo, we inves-
tigated if they remained responsive to external stimuli in vitro and
in vivo. We labeled Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ iNKT
splenocytes with carboxyfluorescein diacetate succinimidyl
ester (CFSE) and cultured them in the presence of a-GalCer or
anti-CD3 and anti-CD28 antibodies for 3 days. Consistent with
their hyperactivated phenotype, iNKT cells from Fasf/fCd19Cre/+
mice underwent greater number of cell divisions compared with
those from Fas+/+Cd19Cre/+ mice (Figure 2J). To ascertain the
relevance of these observations in vivo, we injected mice with
vehicle alone or a-GalCer and sacrificed them 3 days later
to enumerate splenic iNKT cell frequencies. iNKT cells from
Fas+/+Cd19Cre/+ mice expanded by 13.0-fold (0.673% in
vehicle-challenged versus 8.73% in a-GalCer-injected mice;
Figure 2K). iNKT cells from Fasf/fCd19Cre/+ mice also expanded
equivalently by 14.3-fold (0.119% versus 1.70%). Thus, iNKT
cells in mutant mice proliferated normally in response to
a-GalCer (Figure 2L), suggesting that they remained functionally
competent despite being numerically diminished.
As the iNKT cell defects resulted from sole dysregulation of B
cells in Fasf/fCd19Cre/+ mice, we assessed if there were changes
to B cell subset composition in these mice. We examined
CD21hiCD23int MZ, CD21intCD23hi follicular (Foll), and CD21lo
CD23lo or CD11bhiCD11chi age-associated B cell (ABC) subsets.
ABCs were recently identified to be autoreactive cells refractory
to B cell-receptor stimulation but produced cytokines in
response to innate stimuli and were abundant in aged female,
but not male, subjects (Hao et al., 2011; Rubtsov et al., 2011).
We found the frequency of CD21loCD23lo ABCs as a fraction of
B220+CD93 mature B cells to be significantly increased in
aged Fasf/fCd19Cre/+ (23.3%) compared with age-matched
Fas+/+Cd19Cre/+ (4.39%) mice (Figure S2A). The frequency of
Foll B cells concomitantly decreased from 86.1% in Fas+/+
Cd19Cre/+ to 64.4% in Fasf/fCd19Cre/+ mice, while MZ B cell fre-
quency was largely unaffected. Analyses of more mice of each
genotype confirmed the accrual of ABCs in Fasf/fCd19Cre/+
mice (Figure S2B). Total B cells in Fasf/fCd19Cre/+mice were pre-
viously shown to express elevated levels of costimulatory mole-
cules compared with Fas+/+Cd19Cre/+ counterparts (Hao et al.,
2008). Here, we extended the analyses to demonstrate that
ABCs and not MZ or Foll B cells expressed exacerbated levels
of CD80, CD86, and MHCII in Fasf/fCd19Cre/+ mice (Figure S2C).
Because the semi-invariant TCRs of iNKT cells recognize
glycolipid antigens presented by CD1d on antigen-presenting
cells, we assessed if CD1d expression on autoimmune FAS-defi-
cient B cells was altered. Previously, human activated or mem-
ory B cells were shown to express lower levels of CD1d
compared with naive or MZ-like B cells and resting B cells
activated via B cell receptor or CD40L in vitro downregulated
CD1d (Allan et al., 2011). It was proposed that immature
CD19+CD24hiCD38hi SLE B cells failed to support iNKT cell sur-
vival due to their reduced CD1d levels. In contrast, we found
CD1d expression on Fasf/fCd19Cre/+ MZ B, Foll B, or ABCs to
be largely comparable to that found on Fas+/+Cd19Cre/+ counter-
parts (Figure S2D), ruling out changes in CD1d expression on
FAS-deficient B cells as contributing to diminished iNKT fre-
quencies in autoimmune mice (Figure 1).
We therefore hypothesized that iNKT depletion in Fasf/f
Cd19Cre/+ mice arose from overstimulation of iNKT cells by
CD1d-restricted self-lipids fromautoimmuneB cells. If decreased
CD1d expression in B cells led to iNKT diminution in autoimmune
mice, one predicted consequence of removing CD1dwould be to
further deplete residual iNKT cells. Surprisingly, this was not the
case, as we found appreciable restoration of iNKT cell fre-
quencies and numbers in spleens, livers, and bone marrows ofFasf/fCd1d1f/fCd19Cre/+ mice in which CD1d expression was ab-
lated specifically in B cells, compared with Fasf/fCd1d1+/+
Cd19Cre/+mice (Figures 3A and 3B). Concomitant with the rescue
of iNKT cell frequencies in Fasf/fCd1d1f/fCd19Cre/+ mice, we
observed substantial correction of augmented PD-1 and ICOS
expression (Figure 3C) and altered cytokine production (Fig-
ure 3D) in iNKT cells. This CD1d-dependent suppression of
iNKT cells by autoimmune B cells adds a different perspective
to previous data showing the reverse, inwhich iNKT cells inhibited
autoreactive B cell activation and autoantibody production trig-
gered genetically (Yang et al., 2011) or by systemic loading of
apoptotic cells (Wermeling et al., 2010). However, as there was
incomplete rescue of iNKT cell numbers in Fasf/fCd1d1f/f
Cd19Cre/+ mice, CD1d-mediated presentation of self-lipids by
autoimmuneB cells probably represents one of several pathways
affecting iNKT cells in Fasf/fCd1d1+/+Cd19Cre/+ mice.
Importantly, our data suggest that CD1d-mediated self-lipid
presentation by autoimmune, but not healthy, B cells actively
depleted iNKT cells in Fasf/fCd1d1+/+Cd19Cre/+ mice, since
CD1d loss in B cells of nonautoimmune Fas+/+Cd1d1f/fCd19Cre/+
mice (Figure S3A) did not affect iNKT frequencies and numbers
in various organs (Figure S3B). These results suggest that
CD1d-mediated presentation of self-lipids is essential for iNKT
maturation in the thymus (Gapin et al., 2001) of normal mice
and also impacts peripheral iNKT homeostasis in autoimmune
mice.
We next examined if FAS-deficient ABCs could deplete
normal iNKT cells in a CD1d-dependent manner in vitro. We co-
cultured 23 106 ABCs enriched from spleens of Fas+/+Cd1d1+/+
Cd19Cre/+, Fasf/fCd1d1+/+Cd19Cre/+ or Fasf/fCd1d1f/fCd19Cre/+
mice with 2 3 105 CFSE-labeled wild-type iNKT cells enriched
from thymi of C57BL/6 mice for 3 days. The frequency of iNKT
cells was decreased from 3.22% when they were cocultured
with FAS-sufficient ABCs to 0.672% when they were incubated
with FAS-deficient ABCs (Figure 3E). Importantly, iNKT cell fre-
quency remained largely unaffected (2.68%) when they were co-
cultured with FAS-deficient ABCs that also lack CD1d. It is
possible that the expansion of and hence increase in frequency
of FAS-deficient ABCs led to proportional reduction in iNKT fre-
quency. However, enumeration of cells in cocultures indicated
that the number of iNKT cells was significantly lower when they
were cultured with FAS-deficient compared with FAS-sufficient
ABCs and unperturbed when cultured with FAS-deficient ABCs
that also lacked CD1d (Figure 3F). In addition, iNKT cells prolifer-
ated robustly when cocultured with FAS-deficient ABCs but
weakly when cocultured with FAS-sufficient ABCs or ABCs defi-
cient in both FAS and CD1d (Figure 3G). Similar observations
were made with coculture of 2 3 105 ABCs and 2 3 105 iNKT
cells. Although the frequency of iNKT cells was similar whether
in the presence of FAS-sufficient or deficient ABCs (Figure S4A),
the number of iNKT cells was significantly reduced with FAS-
deficient ABCs but unchanged with ABCs lacking FAS and
CD1d (Figure S4B). In the absence of overt lipid agonists, our
data suggest that FAS-deficient ABCs most likely activated
iNKT cells via CD1d-mediated presentation of endogenous
lipids. Altered expression of PD-1, ICOS, and cytokines
observed in iNKT cells cocultured with FAS-deficient ABCs re-
verted to normalcy when ABCs doubly deficient in FAS andCell Reports 9, 24–31, October 9, 2014 ª2014 The Authors 27
Figure 3. CD1d-Mediated Presentation of Self-Lipids by Autoimmune B Cells Hyperactivates and Depletes iNKT Cells In Vivo and In Vitro
(A and B) Frequencies (A) and numbers (B) of iNKT cells in spleens, livers, and bonemarrows of age-matched Fas+/+Cd1d1+/+Cd19Cre/+, Fasf/fCd1d1+/+Cd19Cre/+,
and Fasf/fCd1d1f/fCd19Cre/+ mice.
(C and D) Expression of ICOS and PD-1 on (C) and cytokine production by (D) iNKT cells from various mice as in (A).
(E–H) In vitro coculture of 2 3 106 splenic ABCs from mice as in (A) with 2 3 105 iNKT cells from thymi of C57BL/6 mice for 3 days. Shown are frequencies (E),
numbers (F), and proliferation and expression of ICOS and PD-1 of (G) and cytokines produced by (H) iNKT cells.
Data in (B) and (F) are mean ± SEM of measurements obtained with four or more mice of each genotype. The rest of data are representative of four or more mice
analyzed. **p < 0.001; ***p < 0.0001; ns, not significant. See also Figures S2–S4.CD1d were employed (Figures 3G and 3H). Together, the data
strongly suggest that autoimmune, but not normal, CD1d+ B
cells present self-lipids via CD1d that hyperactivated and
severely depleted peripheral iNKT cells.
Based on these results and previous work demonstrating the
ability of self-lipids to activate iNKT cells during host immunity
against pathogens (Brennan et al., 2011; Zeissig et al., 2012),
we postulated that altered expression of certain self-lipids in
FAS-deficient B cells, when presented in the context of CD1d,
potentially activated and promoted the apoptosis of iNKT cells.
We hence examined endogenous lipids in splenic B cells from
Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+mice using liquid chromatog-
raphy-mass spectrometry (LC-MS). Profiling of lipid metabolites
revealed changes in the lipidome of autoimmune compared
with normal B cells. Expression levels of selected globotrihexo-28 Cell Reports 9, 24–31, October 9, 2014 ª2014 The Authorssylceramides (Gb3 [d34:1], Gb3 [d42:2], and Gb3 [d42:1]) and
phosphatidylglycerol (PG [32:0]) were increased while that of
cholesterol sulfate was decreased in FAS-deficient compared
with FAS-sufficient B cells (Figure 4A). On the other hand, the
ceramide (Cer [d42:2]) level was unchanged. The molecular
identities of these lipids were verified using MS2 fragmentation
analysis, and Figure 4B shows the example of Gb3 (d42:2),
in which its decomposition yielded the expected daughter
moieties. We further validated the LC-MS results for Gb3 by
using a specific antibody to detect its surface expression on
various B cell subsets from Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+
mice. We found cell-surface Gb3 expression to be confined
primarily to ABCs with little being detected in MZ or Foll B cells.
Interestingly, FAS-deficient ABCs expressed Gb3 at levels
substantially higher than FAS-sufficient cells (Figure 4C). This
Figure 4. Autoimmune FAS-Deficient B Cells Have Altered Lipidome
(A) Intensities of Gb3s (d34:1, d42:2 and d42:1), PG (d32:0), cholesterol sulfate, and ceramide (Cer [d42:2]) in FAS-sufficient and FAS-deficient splenic B cells as
measured by LC-MS.
(B) MS2 spectrum of one of the Gb3s identified in FAS-deficient B cells depicting protonated Gb3 (d42:2) peak (1,134.789 m/z). Fragmentation analysis indicated
all major daughter species were accounted for by stepwise cleavage of three sugar residues. The full molecular structure of Gb3 (d42:2) is shown (right).
(C) Gb3 expression on splenic B cell subsets from Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ mice. Shaded histograms depict staining by isotype control antibody.
(D) Gla transcript levels in FAS-deficient compared with FAS-sufficient ABCs.
(E) Gb3 expression on gated donor CD45.1+ B cells (top) and host CD45.2+ ABCs (bottom) in Fas+/+Cd19Cre/+ or Fasf/fCd19Cre/+ mice 10 days after intravenous
injection of 10 3 106 CD45.1+ B6.SJL splenocytes.
Each symbol in (A) represents a single mouse sample, and small horizontal bars indicate the mean. Data in (C) and (E) are representative of three mice of each
genotype. Data in (D) are mean ± SEM of measurements obtained with three mice. ***p < 0.0001; ns, not significant.complements recent work showing elevated Gb3 in SLE T cells
(McDonald et al., 2014).
A previous study showed lysosomal a-galactosidase A
(a-galA) controlled the generation of self-lipids, and iNKT cells
were numerically reduced in Gla/ mice lacking a-galA
(Darmoise et al., 2010). We found Fasf/fCd19Cre/+mice to pheno-
copyGla/mice in the reduction of iNKT cells. Interestingly, we
also found FAS-deficient ABCs to express significantly reduced
levels of Gla transcript compared with FAS-sufficient ABCs (Fig-
ure 4D), further supporting the hypothesis that autoimmune B
cells, with reduced Gla expression, accumulated altered self-
lipids that overactivated and depleted iNKT cells in Fasf/f
Cd19Cre/+ mice in a CD1d-dependent manner.
To ascertain if enhanced Gb3 expression as a surrogate
biomarker of the altered lipidome of FAS-deficient ABCs is cellintrinsic or an effect of the autoimmune microenvironment, we
adoptively transferred congenically distinguished CD45.1+ sple-
nocytes from B6.SJL mice into Fas+/+Cd19Cre/+ or Fasf/fCd19Cre/+
mice expressing CD45.2. Recipient mice were analyzed at day 10
for Gb3 expression on donor CD45.1+ B cells and host CD45.2+
ABCs. Donor B cells, whether transferred into Fas+/+Cd19Cre/+
or Fasf/fCd19Cre/+ mice, expressed comparable levels of cell-sur-
face Gb3 (Figure 4E, top), suggesting that Gb3 accumulation in
FAS-deficient ABCs is unlikely due to the autoimmune environ-
ment in Fasf/fCd19Cre/+ mice. As before, Gb3 was increased in
CD45.2+ FAS-deficient ABCs compared with FAS-sufficient cells
(Figure 4E, bottom).
In summary, we show that iNKT cell numbers were reduced in
autoimmunemicewith sole dysregulation ofB cells. FAS-deficient
B cells likely presented self-lipids via CD1d that overstimulatedCell Reports 9, 24–31, October 9, 2014 ª2014 The Authors 29
and depleted iNKT cells. Lipidomic profiling revealed alterations in
certain endogenous lipids in FAS-deficient B cells. Future work is
required to determine the identity of ‘‘autoimmune’’ self-lipids and
whether similar lipidome alterations are found in B cells rendered
autoimmune by other genetic lesions. Our data illustrate for that
the lipidome of autoimmune B cells is altered in comparison to
normal B cells and has adverse effects on peripheral iNKT cells.
The findings raise the intriguing possibility that the metabolome
of B cells could impact the homeostasis of other immune cell
types and add to growing evidence of additional B cell function
beyond antibody production.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (CD45.2), B6.SJL (CD45.1), Fasf/f (Hao et al., 2004), Cd1d1f/f (Bai
et al., 2012), and Cd19Cre/+ (Rickert et al., 1995) mice were from The Jackson
Laboratory and bred in our animal facilities under specific-pathogen-free con-
ditions. Experiments withmicewere conducted according to guidelines issued
by A*STAR Biological Resource Centre Institutional Animal Care and Use
Committee.
Cell Suspensions and Flow Cytometry
Spleen, thymus, liver mononuclear, and bone marrow cells were prepared by
standardmethods. Before labeling with relevant fluorochrome-conjugated anti-
bodies, cells were treated with Fc block. iNKT cells were stainedwith allophyco-
cyanin (APC)-conjugated CD1d-PBS57 tetramer and other relevant cell-surface
markers. Antibodies against TCRb (H57-597), B220 (RA3-6B2), CD21/CD35
(7E9), CD23 (B3B4), CD38 (90), CD93 (AA4.1), CD274 (B7-H1/PD-L1;
10F.9G2), CD278 (ICOS; C398.4A), CD279 (PD-1; 29F.1A12), CD45.1 (A20),
CD45.2 (104), phycoerythrin (PE)-Cy7-conjugated streptavidin, and rat immuno-
globulin M (IgM) isotype control antibody (RTK2118) were from BioLegend.
Antibodies against CD69 (H1.2F3), GL7 (GL7), CD28 (37.51), CD134 (OX40;
OX-86), and CD273 (B7-DC/PD-L2; TY25) were from eBioscience. Antibodies
against CD25 (7D4), CD95 (Fas/APO-1; Jo2), CD154 (CD40L; MR1), CD178
(FasL; MFL4), and Ki67 (B56) were from BD Pharmingen. Active caspase-3
expression was visualized using the CaspGLOW Staining Kit (BioVision). Puri-
fied anti-Gb3 (CD77; 38-13) and goat anti-rat IgM were from GenTex. Samples
were acquired on an LSRII cytometer (BD Biosciences) and analyzed with
FlowJo software (Tree Star).
Intracellular Cytokine Production
A total of 53 106 splenocyteswere stimulatedwith 50 ng/ml PMAand 0.5mg/ml
ionomycin (Sigma-Aldrich) in the presence of brefeldin A at 37C for 5 hr. After
staining with surface markers, cells were fixed and permeabilized using the
Cytofix/CytoPerm Kit (BD Pharmingen) and stained with antibodies against
IFN-g (XMG1.2; eBioscience), anti-IL-4 (11B11; BD Pharmingen), or anti-
TNF-a (MP6-XT22; eBioscience).
Splenic iNKT Cell Stimulation
For in vivo studies, mice were injected intraperitoneally with 1 mg BrdU
(Sigma-Aldrich) 24 hr before analysis. Splenic iNKT cells were stained with an-
tibodies against surface markers and processed with FITC BrdU Flow Kit (BD
Pharmingen) before flow cytometric analysis. Mice were also injected with
100 mg/kg of a-GalCer and sacrificed 3 days later to examine splenic iNKT
cell numbers (Harada et al., 2004). For in vitro studies, splenocytes were
labeled with 2 mM CFSE (Invitrogen) and iNKT cells enriched using mouse
NK1.1+ iNKT Cell Isolation Kit (Miltenyi Biotec). a-GalCer (BioVision) was
heated at 80C and sonicated for 10 min. A total of 1 3 105 splenic iNKT
cells were then incubated in the presence of 100 ng/ml sonicated a-GalCer
or 1 mg/ml plate-bound anti-CD3 and 2 mg/ml soluble anti-CD28 for 3 days.
Coculture of ABCs with iNKT Cells
ABCs were enriched from the spleens of Fas+/+Cd1d1+/+Cd19Cre/+, Fasf/f
Cd1d1+/+Cd19Cre/+, and Fasf/fCd1d1f/fCd19Cre/+ mice using PE-conjugated30 Cell Reports 9, 24–31, October 9, 2014 ª2014 The Authorsantibodies against CD21/CD35 (7E9), CD23 (B3B4), and CD43 (S11) (all from
BioLegend) and anti-PE microbeads. iNKT cells were enriched from thymi of
C57BL/6 mice using APC-conjugated CD1d-PBS57 tetramer and anti-APC
microbeads. ABCs were cocultured with CFSE-labeled C57BL/6 iNKT cells
for 3 days.
Adoptive Transfer of CD45.1+ Splenocytes
A tota of 103 106 splenocytes from B6.SJL (CD45.1+) mice were injected into
CD45.2+ Fas+/+Cd19Cre/+ and Fasf/fCd19Cre/+ mice via their lateral tail veins.
Recipient mice sacrificed 10 days after injection were analyzed for splenic
Gb3 expression on donor CD45.1+ B cells and host CD45.2+ ABCs.
RNA Isolation and Quantitative Real-Time PCR
Total RNA was isolated using TRIzol (Invitrogen), precipitated with isopropa-
nol, and cDNA prepared with RevertAid H Minus First-Strand cDNA Synthesis
Kit (Fermentas) using oligo(dT)12–18 as primer. SYBR green Master Mix
(Applied Biosystems) was used for real-time PCR. Primer sequences were
Va14 forward, 50-GTC CTC AGT CCC TGG TTG TC-30; Ja18 reverse, 50-
CAA AAT GCA GCC TCC CTA AG-30; Gla forward, 50-GAC ATT GAT GCG
CAG ACA TTT GA-30; Gla reverse, 50-TTC GGC CTG TCC TGT TCA AG-30;
Ca forward, 50-CCT CTG CCT GTT CAC CGA CTT-30; Ca reverse, 50-CAG
TCA ACG TGG CAT CAC A-30; Actb forward, 50-CCG CGA GCA CAG CTT
CTT TG-30; Actb reverse, 50-ACA TGC CGG AGC CGT TGT C-30. The mRNA
levels of gene transcripts were normalized to those of Ca or Actb (b-actin).
Lipid Extraction and Lipid Profiling with LC-MS
B cells were enriched from the spleens ofmice using anti-CD19-conjugatedmi-
crobeads (Miltenyi Biotec). After centrifugation, B cell pellets were lysed in ice-
coldmethanol:tricine:chloroformmixture. Thechloroform layer containing lipids
was collected and stored at 80C. The chloroform was blown dry with liquid
nitrogen and the lipid extract reconstituted in LC solvents. An ultraperformance
LC Acquity system (Waters Corporation) coupled to a high-resolution mass
spectrometer, XevoQ-TOF (WatersCorporation), was used for intracellular lipid
profiling. The LC-MS data preprocessing was described previously (Chong
et al., 2009; see the Supplemental Experimental Procedures for details of LC
setup parameters). Masses of shortlisted peakswere compared against entries
in the Kyoto Encyclopedia of Genes and Genome and the Human Metabolome
Database. Peaks with matches within a 10 ppm mass accuracy window were
assigned putative identities, some of which were verified bymatching observed
MS2 fragmentation patterns with theoretical fragments generated by Mass
Frontier 5.1software (HighChem) asstandardswere not commercially available.
Statistical Analyses
Differences in values between sampleswere compared by Student’s t test with
Welch’s correction using Prism (GraphPad Software) except for data in Figures
1B, 3B, S1B, and S3B, to which the Mann-Whitney test was applied. Values of
p% 0.05 were regarded as statistically significant.
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